LaClaro’s new service offers a one-time implant payment analysis report that analyzes two years of an ASC’s claims data, according to the release. The report compares the overall accounts receivable timeline for claims with and without implants; breaks that comparison down for each payor and calculates the real costs of implants and compares it to the revenue generated.
“We’ve built in a lot of flexibility in terms of how the analysis is created accommodating for an individual centers’ billing method and contractual agreements,” said Terry Rajendran, LaClaro’s CEO, in the release. “Some of our clients tell us their implant claims used to spend an average of 80 days in accounts receivable. They were able to cut that time in half.”
More Articles Featuring LaClaro:
LaClaro Expands Client Base to 10 States
LaClaro, SourceMedical Become Technology Partners
LaClaro Launches New Revenue Cycle Management Products
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
